Rognstad R
Whitter Institute for Diabetes and Endocrinology, La Jolla, CA 92037.
Biochem J. 1991 Oct 1;279 ( Pt 1)(Pt 1):147-50. doi: 10.1042/bj2790147.
The pathways of peroxisomal and mitochondrial fatty acid oxidation were monitored with the use of substrates which produce NAD3H. I used as marker substrates: D-[3-3H]3-hydroxybutyrate for mitochondrial NAD3H production, [2-3H]glycerol for cytosolic NAD3H production, and [2-3H]acetate to measure carbon-bound 3H which was also generated by the metabolism of the commercial 9,10-3H-labelled fatty acids. The assumption that peroxisomal NAD3H can be considered to be equivalent to cytosolic NAD3H was supported using a specific inhibitor of mitochondrial fatty acid oxidation. The approach involves determination of the specific yields, and the relative distribution on carbons 4 and 6, of 3H in glucose from the marker substrates and the labelled fatty acids. In hepatocytes from clofibrate-treated rats, the amount of palmitate or oleate oxidation which starts in the peroxisomes is comparable with that which starts in the mitochondria.
利用产生NAD⁺H的底物监测过氧化物酶体和线粒体脂肪酸氧化途径。我使用了以下标记底物:用于线粒体产生NAD⁺H的D-[3-³H]3-羟基丁酸、用于胞质溶胶产生NAD⁺H的[2-³H]甘油,以及[2-³H]乙酸盐来测量与碳结合的³H,其也由市售的9,10-³H标记脂肪酸的代谢产生。使用线粒体脂肪酸氧化的特异性抑制剂支持了过氧化物酶体NAD⁺H可被视为等同于胞质溶胶NAD⁺H的假设。该方法涉及测定来自标记底物和标记脂肪酸的葡萄糖中³H的特定产量以及在碳4和碳6上的相对分布。在氯贝丁酯处理的大鼠的肝细胞中,起始于过氧化物酶体的棕榈酸酯或油酸酯氧化量与起始于线粒体的氧化量相当。